Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSIW) Other Working Capital Changes (2022 - 2025)

TriSalus Life Sciences' Other Working Capital Changes history spans 4 years, with the latest figure at $514000.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 1385.0% year-over-year to $514000.0; the TTM value through Dec 2025 reached -$134000.0, up 51.8%, while the annual FY2025 figure was -$134000.0, 51.8% up from the prior year.
  • Other Working Capital Changes reached $514000.0 in Q4 2025 per TLSIW's latest filing, up from -$567000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.4 million in Q3 2022 to a low of -$1.4 million in Q4 2022.
  • Average Other Working Capital Changes over 4 years is -$95687.5, with a median of -$78500.0 recorded in 2023.
  • The largest YoY upside for Other Working Capital Changes was 1385.0% in 2025 against a maximum downside of 733.82% in 2025.
  • A 4-year view of Other Working Capital Changes shows it stood at -$1.4 million in 2022, then surged by 40.42% to -$830000.0 in 2023, then surged by 95.18% to -$40000.0 in 2024, then soared by 1385.0% to $514000.0 in 2025.
  • Per Business Quant, the three most recent readings for TLSIW's Other Working Capital Changes are $514000.0 (Q4 2025), -$567000.0 (Q3 2025), and $430000.0 (Q2 2025).